Replies to post #424075 on Amarin Corp Plc (AMRN)

[ramfan60]

Why wouldn't they spend time and money on a patent....... it's not that much time and it's not that much money. They don't have to do any lengthy study either..... just get the patent and add it to your patent portfolio to increase the value of the company.

[JRoon71]

I have to agree with Kiwi on this. Amarin already knows about the migraine issue. They are aware of anything and everything that goes on with IPE.

But I also don't believe that Amarin has the time, resources, or interest to chase new indications that are not central to their goal. I believe Denner wants to focus on getting V rolled out in Europe, finish out the litigation efforts in the U.S. (whatever might come of that), possibly do something with the new formulations (LrEtEPA, MND-2119), and get this thing sold.

The other indications and formulations...colorectal cancer, migraines, FDC, etc. are likely something to be dangled in front of a BP as a future opportunity.

I may be wildly wrong, but there does not seem to be any effort or money being spent on R&D right now, which would be the big indicator that something was going on.